SCHEMBL17183003

SCHEMBL17183003

CCCCCCCC/C=C\CCCCCCCCN(CCCCCCCC/C=C\CCCCCCCC)C(=O)C(C)CN(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 5/20 0.47
TERT O14746 3/20 0.42
PTPN1 P18031 3/20 0.42
PPARG P37231 3/20 0.42
PPARD Q03181 3/20 0.42
PPARA Q07869 3/20 0.42
CYP1A2 P05177 2/20 0.42
MAPT P10636 2/20 0.42
CYP2C19 P33261 2/20 0.42
BLM P54132 2/20 0.42
HSD17B10 Q99714 2/20 0.42
FABP4 P15090 2/20 0.42
FAAH O00519 2/20 0.42
KMT2A Q03164 2/20 0.42
TOP1 P11387 2/20 0.42
GMNN O75496 1/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22814023 0.82 ALDH1A1 (0.50) PPARGPPARDPPARAHSD17B10FABP4
SCHEMBL28450589 0.80 EPHX2 (0.50) EPHX2TERTPTPN1PPARGPPARD
SCHEMBL158056 0.78 EPHX2 (0.48) EPHX2TERTPTPN1PPARGPPARD
SCHEMBL158797 0.77 ALDH1A1 (0.51) EPHX2PPARGPPARDPPARAHSD17B10
SCHEMBL27857048 0.77 FAAH (0.49) EPHX2CYP1A2MAPTCYP2C19BLM
SCHEMBL25140 0.76 ALDH1A1 (0.43) PPARGPPARDPPARAMAPTHSD17B10
SCHEMBL14341514 0.76 CA1 (0.44) MMP2
SCHEMBL15238201 0.76 EPHX2 (0.58) EPHX2TERTPTPN1PPARGPPARD
SCHEMBL14341515 0.76 CA1 (0.44) MMP2
SCHEMBL15238203 0.76 EPHX2 (0.58) EPHX2TERTPTPN1PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150297749-A1 LOW-DENSITY LIPOPROTEIN ANALOGUE NANOPARTICLES, AND COMPOSITION COMPRISING SAME FOR TARGETED DIAGNOSIS AND TREATMENT OF LIVER POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2015-10-22 US claimed
CN-117945938-A Tris (hydroxymethyl) methylglycine and citrate lipids 川斯勒佰尔公司 2024-04-30 CN disclosed
CN-114401942-B Tris (hydroxymethyl) methylglycine and citrate lipids 川斯勒佰尔公司 2024-01-26 CN disclosed
CN-117430538-A Thioester cationic lipids 川斯勒佰尔公司 2024-01-23 CN disclosed
CN-112437767-B thioester cationic lipids 川斯勒佰尔公司 2023-10-27 CN disclosed
CN-115154620-A CFTR MRNA compositions and related methods and uses 夏尔人类遗传性治疗公司 2022-10-11 CN disclosed
CN-115135335-A In vitro and in vivo gene delivery to immune effector cells using nanoparticles functionalized with Designed Ankyrin Repeat Proteins (DARPIN) 生物技术细胞和基因治疗公司 2022-09-30 CN disclosed
CN-114401942-A Tris (hydroxymethyl) methylglycine and citrate esters 川斯勒佰尔公司 2022-04-26 CN disclosed
CN-114344275-A Encapsulation of messenger RNA 川斯勒佰尔公司 2022-04-15 CN disclosed
CN-114146063-A Encapsulation of messenger RNA 川斯勒佰尔公司 2022-03-08 CN disclosed
CN-106456547-B Encapsulation of messenger RNA 川斯勒佰尔公司 2021-11-12 CN disclosed
CN-113423418-A Treatment of cilia disease 埃泽瑞斯公司 2021-09-21 CN disclosed
CN-113412273-A Compositions and methods for treating primary ciliary dyskinesia 川斯勒佰尔公司 2021-09-17 CN disclosed
CN-112888451-A Pump-free encapsulation of messenger RNA 川斯勒佰尔公司 2021-06-01 CN disclosed
CN-112839639-A Improved method for preparing mRNA loaded lipid nanoparticles 川斯勒佰尔公司 2021-05-25 CN disclosed
CN-112672761-A Phosphate cationic lipids 川斯勒佰尔公司 2021-04-16 CN disclosed
CN-112533909-A Vitamin cationic lipid 川斯勒佰尔公司 2021-03-19 CN disclosed
CN-112437767-A Thioester cationic lipids 川斯勒佰尔公司 2021-03-02 CN disclosed
CN-112424214-A Cationic lipids comprising steroidal moieties 川斯勒佰尔公司 2021-02-26 CN disclosed